Get Premium to unlock powerful stock data

Prosight Management, LP Buys Galapagos NV, Albireo Pharma Inc, Accolade Inc, Sells Haemonetics Corp, Prothena Corp PLC, Encompass Health Corp

Author's Avatar
insider
Nov 13, 2021
Article's Main Image
Investment company Prosight Management, LP (Current Portfolio) buys Galapagos NV, Albireo Pharma Inc, Accolade Inc, Humana Inc, Shattuck Labs Inc, sells Haemonetics Corp, Prothena Corp PLC, Encompass Health Corp, R1 RCM Inc, Zimmer Biomet Holdings Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Prosight Management, LP. As of 2021Q3, Prosight Management, LP owns 43 stocks with a total value of $182 million. These are the details of the buys and sells.

For the details of Prosight Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/prosight+management%2C+lp/current-portfolio/portfolio

These are the top 5 holdings of Prosight Management, LP
  1. Prothena Corp PLC (PRTA) - 323,300 shares, 12.67% of the total portfolio. Shares reduced by 23.39%
  2. Albireo Pharma Inc (ALBO) - 445,020 shares, 7.64% of the total portfolio. Shares added by 50.81%
  3. Galapagos NV (GLPG) - 250,680 shares, 7.26% of the total portfolio. Shares added by 248.17%
  4. Cue Biopharma Inc (CUE) - 655,185 shares, 5.25% of the total portfolio. Shares added by 3.94%
  5. Arena Pharmaceuticals Inc (ARNA) - 153,400 shares, 5.03% of the total portfolio. Shares added by 11.97%
New Purchase: Accolade Inc (ACCD)

Prosight Management, LP initiated holding in Accolade Inc. The purchase prices were between $41.3 and $54.56, with an estimated average price of $47.11. The stock is now traded at around $36.380000. The impact to a portfolio due to this purchase was 2.27%. The holding were 97,988 shares as of 2021-09-30.

New Purchase: Humana Inc (HUM)

Prosight Management, LP initiated holding in Humana Inc. The purchase prices were between $389.15 and $471.22, with an estimated average price of $424.73. The stock is now traded at around $445.420000. The impact to a portfolio due to this purchase was 1.93%. The holding were 9,000 shares as of 2021-09-30.

New Purchase: Shattuck Labs Inc (STTK)

Prosight Management, LP initiated holding in Shattuck Labs Inc. The purchase prices were between $17.57 and $28.95, with an estimated average price of $21.5. The stock is now traded at around $12.480000. The impact to a portfolio due to this purchase was 1.9%. The holding were 169,241 shares as of 2021-09-30.

New Purchase: Amedisys Inc (AMED)

Prosight Management, LP initiated holding in Amedisys Inc. The purchase prices were between $149.1 and $270.32, with an estimated average price of $208.37. The stock is now traded at around $182.790000. The impact to a portfolio due to this purchase was 1.64%. The holding were 20,000 shares as of 2021-09-30.

New Purchase: Agilon Health Inc (AGL)

Prosight Management, LP initiated holding in Agilon Health Inc. The purchase prices were between $26.15 and $38.72, with an estimated average price of $34.27. The stock is now traded at around $25.510000. The impact to a portfolio due to this purchase was 1.58%. The holding were 109,510 shares as of 2021-09-30.

New Purchase: AbbVie Inc (ABBV)

Prosight Management, LP initiated holding in AbbVie Inc. The purchase prices were between $106.4 and $120.78, with an estimated average price of $114.24. The stock is now traded at around $116.970000. The impact to a portfolio due to this purchase was 1.47%. The holding were 24,800 shares as of 2021-09-30.

Added: Galapagos NV (GLPG)

Prosight Management, LP added to a holding in Galapagos NV by 248.17%. The purchase prices were between $52.17 and $70.2, with an estimated average price of $59.52. The stock is now traded at around $52.820000. The impact to a portfolio due to this purchase was 5.17%. The holding were 250,680 shares as of 2021-09-30.

Added: Albireo Pharma Inc (ALBO)

Prosight Management, LP added to a holding in Albireo Pharma Inc by 50.81%. The purchase prices were between $27.36 and $35.98, with an estimated average price of $30.98. The stock is now traded at around $28.950000. The impact to a portfolio due to this purchase was 2.57%. The holding were 445,020 shares as of 2021-09-30.

Added: Iovance Biotherapeutics Inc (IOVA)

Prosight Management, LP added to a holding in Iovance Biotherapeutics Inc by 97.83%. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $21.070000. The impact to a portfolio due to this purchase was 1.84%. The holding were 274,761 shares as of 2021-09-30.

Added: Zogenix Inc (ZGNX)

Prosight Management, LP added to a holding in Zogenix Inc by 60.53%. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $15.490000. The impact to a portfolio due to this purchase was 1.55%. The holding were 490,882 shares as of 2021-09-30.

Added: Convey Health Solutions Holdings Inc (CNVY)

Prosight Management, LP added to a holding in Convey Health Solutions Holdings Inc by 79.82%. The purchase prices were between $7.75 and $11.35, with an estimated average price of $8.94. The stock is now traded at around $7.570000. The impact to a portfolio due to this purchase was 1.51%. The holding were 738,012 shares as of 2021-09-30.

Added: Oscar Health Inc (OSCR)

Prosight Management, LP added to a holding in Oscar Health Inc by 242.55%. The purchase prices were between $12.25 and $21.25, with an estimated average price of $17.05. The stock is now traded at around $12.180000. The impact to a portfolio due to this purchase was 1.27%. The holding were 188,400 shares as of 2021-09-30.

Sold Out: R1 RCM Inc (RCM)

Prosight Management, LP sold out a holding in R1 RCM Inc. The sale prices were between $18.85 and $22.55, with an estimated average price of $20.69.

Sold Out: Quantum-Si Inc (QSI)

Prosight Management, LP sold out a holding in Quantum-Si Inc. The sale prices were between $7.97 and $13.56, with an estimated average price of $9.88.

Sold Out: LHC Group Inc (LHCG)

Prosight Management, LP sold out a holding in LHC Group Inc. The sale prices were between $156.91 and $215.29, with an estimated average price of $187.92.

Sold Out: Aurinia Pharmaceuticals Inc (AUPH)

Prosight Management, LP sold out a holding in Aurinia Pharmaceuticals Inc. The sale prices were between $10.93 and $23.55, with an estimated average price of $15.85.

Sold Out: ATI Physical Therapy Inc (ATIP)

Prosight Management, LP sold out a holding in ATI Physical Therapy Inc. The sale prices were between $3.39 and $9.42, with an estimated average price of $5.14.

Sold Out: Medtronic PLC (MDT)

Prosight Management, LP sold out a holding in Medtronic PLC. The sale prices were between $122.75 and $135.17, with an estimated average price of $129.47.



Here is the complete portfolio of Prosight Management, LP. Also check out:

1. Prosight Management, LP's Undervalued Stocks
2. Prosight Management, LP's Top Growth Companies, and
3. Prosight Management, LP's High Yield stocks
4. Stocks that Prosight Management, LP keeps buying
Rating:
NaN / 5 ( votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus